Hongbo Liu

Zhenhao Shuai, Hongbo Liu, Zhaolin Wan et al. · tencent-ai

Neuroevolution has greatly promoted Deep Neural Network (DNN) architecture design and its applications, while there is a lack of methods available across different DNN types concerning both their scale and performance. In this study, we propose a self-adaptive neuroevolution (SANE) approach to automatically construct various lightweight DNN architectures for different tasks. One of the key settings in SANE is the search space defined by cells and organs self-adapted to different DNN types. Based on this search space, a constructive evolution strategy with uniform evolution settings and operations is designed to grow DNN architectures gradually. SANE is able to self-adaptively adjust evolution exploration and exploitation to improve search efficiency. Moreover, a speciation scheme is developed to protect evolution from early convergence by restricting selection competition within species. To evaluate SANE, we carry out neuroevolution experiments to generate different DNN architectures including convolutional neural network, generative adversarial network and long short-term memory. The results illustrate that the obtained DNN architectures could have smaller scale with similar performance compared to existing DNN architectures. Our proposed SANE provides an efficient approach to self-adaptively search DNN architectures across different types.

Hongbo Liu, Siyi Li, Zheng Yu

Drug-drug interactions (DDIs) are a major concern in clinical practice, as they can lead to reduced therapeutic efficacy or severe adverse effects. Traditional computational approaches often struggle to capture the complex relationships among drugs, targets, and biological entities. In this work, we propose HGNN-DDI, a heterogeneous graph neural network model designed to predict potential DDIs by integrating multiple drug-related data sources. HGNN-DDI leverages graph representation learning to model heterogeneous biomedical networks, enabling effective information propagation across diverse node and edge types. Experimental results on benchmark DDI datasets demonstrate that HGNN-DDI outperforms state-of-the-art baselines in prediction accuracy and robustness, highlighting its potential to support safer drug development and precision medicine.